Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Weighted-Average Discount Rate

Weighted-Average Discount Rate at other companies

Roivant Sciences logo
Roivant SciencesROIV
——

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's weighted-average discount rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's weighted-average discount rate?
BioCryst Pharmaceuticals (BCRX) reported weighted-average discount rate of 9.9% in Q1 2026.
How has BioCryst Pharmaceuticals's weighted-average discount rate changed year-over-year?
BioCryst Pharmaceuticals's weighted-average discount rate increased by 8.2% year-over-year, from 9.1% to 9.9%.
What is the long-term trend for BioCryst Pharmaceuticals's weighted-average discount rate?
Over 2 years (2023 to 2025), BioCryst Pharmaceuticals's weighted-average discount rate has grown at a 14.4% compound annual growth rate (CAGR), from 7.5% to 9.8%.
What does weighted-average discount rate mean?
This represents the average interest rate used to calculate the present value of the company's lease liabilities. It reflects the company's incremental borrowing rate or the rate implicit in the leases. This metric is essential for understanding the cost of capital embedded in the company's off-balance-sheet financing arrangements.